Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06672185 · ClinicalTrials.gov registry record · Phase 1

ARC101 in Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by Third Arc Bio.

Recruiting
Registry status
Phase 1
Development phase
70
Enrollment target
10
Study locations

NCT06672185 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by Third Arc Bio. The registered enrollment target is 70 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (64% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06672185, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by Third Arc Bio.

RECRUITING
Registry status
Phase 1
Development phase
70 participants
Enrollment target
10
Study locations

Study Summary

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of ARC101 in patients with advanced cancer.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG ARC101

Study Locations (10)

Other

  • Rambam Medical Center - Haifa
  • Sheba Medical Center - Ramat Gan
  • Sourasky Medical Center - Tel Aviv

Michigan

  • START Midwest - Grand Rapids

Texas

  • START San Antonio, LLC. - San Antonio

Queensland

  • Sunshine Coast University Private Hospital - Birtinya

South Australia

  • Cancer Research SA - Adelaide

Victoria

  • Cabrini Health Research - Malvern

British Columbia

  • BC Cancer Research Centre - Vancouver

Ontario

  • The Princess Margaret Cancer Centre - Toronto

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-02-05
Est. Completion 2028-08-01
Phase Phase 1

Sponsor

Third Arc Bio

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06672185

The ClinicalTrials.gov registry entry for NCT06672185 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (64% lower). The listed sponsor is Third Arc Bio, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which ARC101 is the first listed.

NCT06672185 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Other, Michigan, Texas.

Frequently Asked Questions

What is clinical trial NCT06672185 about?

NCT06672185 is a clinical study titled "ARC101 in Advanced Solid Tumors". This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of ARC101 in patients with advanced cancer.

What is the current status of trial NCT06672185?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 70 participants. The study started on 2025-02-05. Estimated completion is 2028-08-01.

What conditions does trial NCT06672185 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT06672185?

The interventions under investigation include: ARC101 (DRUG).

Who is sponsoring clinical trial NCT06672185?

This trial is sponsored by Third Arc Bio, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06672185 being conducted?

This trial has 10 study locations across Michigan, Texas, Queensland, South Australia, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.